Parkinsonís Disease Research Tools Consortium
Researchers rely on critical tools, such as laboratory reagents and pre-clinical models, to understand the causes and mechanisms underlying disease and to develop effective treatments. When such tools are unavailable, investigators often must make their own, dedicating time and resources that would be better spent studying disease. Many existing tools lack sufficient quality control data, are difficult to obtain by the wider research community, or may come with restrictive license terms and fees that hinder drug-makersí ability to use them. Promoting the generation and availability of critical research tools is a key way to accelerate therapeutic development for Parkinsonís patients.
To drive tool development toward the greatest needs of the field, the Foundation is spearheading the Parkinsonís Disease Research Tools Consortium. Via this precompetitive consortium,†MJFF and industry partners work to better understand existing tools and their use in laboratory experiments, as well as to develop new tools to address unmet challenges.
Industry groups interested in joining the consortium are invited to contact us for more information at email@example.com .
Tools Priority Area
Learn more about why weíre investing in research tools and our 2014 priorities.